Amgen (AMGN) Declares $1.15 Quarterly Dividend; 2.6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
Amgen Announces 2017 Fourth Quarter Dividend
October 24, 2017 4:00 PM EDTTHOUSAND OAKS, Calif., Oct. 24, 2017 /PRNewswire/ --Â Amgen (NASDAQ: AMGN) today announced that its Board of Directors declared a $1.15 per share dividend for the fourth quarter of 2017. The dividend will be paid on Dec. 8, 2017, to all stockholders of record as of the close of business on Nov. 17, 2017.
About AmgenAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and... More
